What is ETNB's current stock price?

ETNB (89bio, Inc.) is currently trading at $14.84 with a market cap of $2.20B.

What sector is 89bio, Inc. in?

89bio, Inc. (ETNB) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

ETNB 89bio, Inc.

NASDAQHealthcare

$14.84+0.00%ClosedMarket Cap: $2.20B

As of 2025-10-30 16:00

Why ETNB matters now

89bio, Inc. (ETNB) is a US stock in Healthcare. The latest InvestLog snapshot shows $14.84 with +0.00% on the session and $2.20B in market capitalization.

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

NASDAQ

Beta

1.26

Operating as a clinical-stage biopharmaceutical company, 89bio, Inc. is dedicated to advancing and commercializing therapeutic solutions for ailments impacting the liver and metabolic system. Their flagship product candidate, pegozafermin, is a modified fibroblast growth factor 21 (FGF21) analog specifically designed to address nonalcoholic steatohepatitis (NASH). Furthermore, the company has plans to explore pegozafermin's utility in treating severe hypertriglyceridemia. Founded in 2018, 89bio, Inc. maintains its corporate headquarters in San Francisco, California.